Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients aged 18 years and older~* urologic elective ambulatory procedure. For example:cystoscopy, circumcision,transurethral bladder tumor resection, varicocele and hydrocele surgery~* gynecologic elective ambulatory procedure. For example: hysteroscopy, vulvar ou vaginal biopsy~* general surgery elective ambulatory procedure. For example:inguinal herniorraphy, short ano-rectal procedure~Exclusion Criteria:~* INR \> 1,3~* platelet \< 75 000~* concomitant drugs: clopidogrel (last dose \< 7 days), iv heparin, low molecular weight heparin (last dose \< 24 hours)~* neurologic disease: spinal stenosis, symptomatic lumbar herniated disc, multiple sclerosis~* liquid restriction (cardiac or renal insufficiency)~* allergy or intolerance to chloroprocaine, bupivacaine or PABA~* atypical plasma cholinesterase or deficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chloroprocaine (Type: ACTIVE_COMPARATOR): None
- Bupivacaine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).